alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Thrombosis in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morrell, CN | 1 |
Sun, H | 1 |
Ikeda, M | 1 |
Beique, JC | 1 |
Swaim, AM | 1 |
Mason, E | 1 |
Martin, TV | 1 |
Thompson, LE | 1 |
Gozen, O | 1 |
Ampagoomian, D | 1 |
Sprengel, R | 1 |
Rothstein, J | 1 |
Faraday, N | 1 |
Huganir, R | 1 |
Lowenstein, CJ | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Thrombosis
Article | Year |
---|---|
Glutamate mediates platelet activation through the AMPA receptor.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anim | 2008 |